FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

DHILLON AVTAR S 		2. Issuer Name and Ticker or Trading Symbol

ONCOSEC MEDICAL Inc [ ONCS ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

3565 GENERAL ATOMICS COURT #100 		3. Date of Earliest Transaction (MM/DD/YYYY)

6/15/2018
(Street)

SAN DIEGO, CA 92121
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   6/15/2018     M    100000   A   (1) 181002   D    
Common Stock   (2) 6/18/2018     S    5552   D $1.386   175450   D    
Common Stock   (2) 6/19/2018     S    1838   D $1.364   173612   D    
Common Stock   (2) 6/20/2018     S    10973   D $1.422   162639   D    
Common Stock   (2) 6/21/2018     S    2178   D $1.401   160461   D    
Common Stock   (2) 6/22/2018     S    2956   D $1.418   157505   D    
Common Stock   (2) 6/25/2018     S    202   D $1.405   157303   D    
Common Stock   (2) 6/26/2018     S    4703   D $1.398   152600   D    
Common Stock   (2) 6/27/2018     S    3451   D $1.374   149149   D    
Common Stock   (2) 6/28/2018     S    1556   D $1.401   147593   D    
Common Stock   (2) 6/29/2018     S    1066   D $1.380   146527   D    
Common Stock   (2) 7/5/2018     S    3100   D $1.312   143427   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units     (1) 6/15/2018     M         100000    3/4/2019   3/4/2019   Common Stock   100000   $0   0   D    

Explanation of Responses:
(1)  Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
(2)  Sale to cover taxes on restricted stock unit vesting.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
DHILLON AVTAR S
3565 GENERAL ATOMICS COURT #100
SAN DIEGO, CA 92121 		X



Signatures
/s/ Avtar S. Dhillon 7/6/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
OncoSec Medical (NASDAQ:ONCS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more OncoSec Medical Charts.
OncoSec Medical (NASDAQ:ONCS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more OncoSec Medical Charts.